LHRH agonists in prostate cancer: frequency of treatment, serum testosterone measurement and castrate level: consensus opinion from a roundtable discussion-Reference-Cited by-同舟云学术

LHRH agonists in prostate cancer: frequency of treatment, serum testosterone measurement and castrate level: consensus opinion from a roundtable discussion

Published:2007-04-11 Issue:5 Volume:23 Page:1077-1080
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Jan de Jong Igle¹,Eaton Alan²,Bladou Franck³

Affiliation:

1. Department of Urology, University Medical Center Groningen, University of Groningen, The Netherlands

2. Department of Urology, Queen Elizabeth Hospital, King's Lynn, UK

3. Department of Urology, Hôpital Sainte Marguerite, Marseille, France

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/030079907X187973

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term Surgical and Chemical Castration Deteriorates Memory Function Through Downregulation of PKA/CREB/BDNF and c-Raf/MEK/ERK Pathways in Hippocampus;International Neurourology Journal;2019-06-30

2. A New Sustained-release, 3-Month Leuprolide Acetate Formulation Achieves and Maintains Castrate Concentrations of Testosterone in Patients With Prostate Cancer;Clinical Therapeutics;2019-03

3. Treatment Patterns and Trends in Patients Dying of Prostate Cancer in Quebec: A Population-Based Study;Current Oncology;2017-08-01

4. Study of testosterone-guided androgen deprivation therapy in management of prostate cancer;The Prostate;2015-11-02

5. The Transport and Efflux of Glycosylated Luteinising Hormone-Releasing Hormone Analogues in Caco-2 Cell Model: Contributions of Glucose Transporters and Efflux Systems;Journal of Pharmaceutical Sciences;2014-10